+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cancer Profiling Market by Technique, by Technology, by Cancer Type, and by Application: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018 - 2025

  • PDF Icon

    Report

  • 110 Pages
  • April 2019
  • Region: Global
  • Zion Market Research
  • ID: 4853836

The report covers a forecast and an analysis of the cancer profiling market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the cancer profiling market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the cancer profiling market on a global level.



In order to give the users of this report a comprehensive view of the cancer profiling market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.



The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new assay kits launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market.



The study provides a decisive view of the cancer profiling market on the basis of technique, technology, cancer type, application, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.



Some key players of the global cancer profiling market are HTG Molecular Diagnostic, Illumina, NeoGenomics Laboratories, QIAGEN, Caris Life Sciences, Helomics Corporation, Oxford Gene Technology, Genomic Health, NanoString Technologies, and RiboMed Biotechnologies.



This report segments the global cancer profiling market as follows:



Global Cancer Profiling Market: Technique Analysis



  • Genomics
  • Proteomics
  • Metabolomics
  • Epigenetics

Global Cancer Profiling Market: Technology Analysis



  • Immunoassay
  • Hybridization
  • Next-Generation Sequencing
  • Mass Spectroscopy
  • Others

Global Cancer Profiling Market: Cancer Type Analysis



  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Melanoma Cancer
  • Others

Global Cancer Profiling Market: Application Analysis



  • Personalized Cancer Medicine
  • Oncological Diagnostics
  • Research
  • Others

Global Cancer Profiling Market: Regional Analysis



  • North America
  • The U.S.

  • Europe
  • UK
  • France
  • Germany

  • Asia Pacific
  • China
  • Japan
  • India

  • Latin America
  • Brazil

  • Middle East and Africa

Table of Contents

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global cancer profiling market, 2016-2025 (USD Billion)
    • 2.2. Global cancer profiling market: Snapshot
  • Chapter 3. Cancer Profiling Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global cancer profiling market drivers: Impact analysis
      • 3.2.2. Increasing Number of New Cancer Cases
      • 3.2.3. Increasing Utility of Biomarkers in Tumor Profiling
      • 3.2.4. Availability of Funding for Cancer Research
    • 3.3. Market Restraints
      • 3.3.1. Global cancer profiling market restraints: Impact analysis
      • 3.3.2. High Capital Investments and Low Benefit Ratio for Biomarkers
      • 3.3.3. Lack of Skilled Professionals and Infrastructure
    • 3.4. Opportunities
      • 3.4.1. Point-Of-Care Diagnostic Tests
      • 3.4.2. Increasing Demand for Personalized Medicine
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by technique
      • 3.6.2. Market attractiveness analysis, by technology
      • 3.6.3. Market attractiveness analysis, by cancer type
      • 3.6.4. Market attractiveness analysis, by application
      • 3.6.5. Market attractiveness analysis, by region
  • Chapter 4. Global Cancer Profiling Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global cancer profiling market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New instruments launch
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  • Chapter 5. Global Cancer Profiling Market - Technique Analysis
    • 5.1. Global cancer profiling market: Technique overview
      • 5.1.1. Global cancer profiling market revenue share, by technique, 2018 and 2025
    • 5.2. Genomics
      • 5.2.1. Global cancer profiling market for genomics, 2016-2025 (USD Billion)
    • 5.3. Proteomics
      • 5.3.1. Global cancer profiling market for proteomics, 2016-2025 (USD Billion)
    • 5.4. Metabolomics
      • 5.4.1. Global cancer profiling market for metabolomics, 2016-2025 (USD Billion)
    • 5.5. Epigenetics
      • 5.5.1. Global cancer profiling market for epigenetics, 2016-2025 (USD Billion)
  • Chapter 6. Global Cancer Profiling Market - Technology Analysis
    • 6.1. Global cancer profiling market: Technology overview
      • 6.1.1. Global cancer profiling market revenue share, by technology, 2018 and 2025
    • 6.2. Immunoassays
      • 6.2.1. Global cancer profiling market for immunoassays, 2016-2025 (USD Billion)
    • 6.3. Hybridization
      • 6.3.1. Global cancer profiling market for hybridization, 2016-2025 (USD Billion)
    • 6.4. Next-Generation Sequencing
      • 6.4.1. Global cancer profiling market for Next-Generation sequencing, 2016-2025 (USD Billion)
    • 6.5. Mass Spectroscopy
      • 6.5.1. Global cancer profiling market for mass spectroscopy, 2016-2025 (USD Billion)
    • 6.6. Others
      • 6.6.1. Global cancer profiling market for others, 2016-2025 (USD Billion)
  • Chapter 7. Global Cancer Profiling Market - Cancer Type Analysis
    • 7.1. Global cancer profiling market: Cancer Type overview
      • 7.1.1. Global cancer profiling market revenue share, by cancer type, 2018 and 2025
    • 7.2. Colorectal Cancer
      • 7.2.1. Global cancer profiling market for colorectal cancer, 2016-2025 (USD Billion)
    • 7.3. Prostate Cancer
      • 7.3.1. Global cancer profiling market for prostate cancer, 2016-2025 (USD Billion)
    • 7.4. Breast Cancer
      • 7.4.1. Global cancer profiling market for breast cancer, 2016-2025 (USD Billion)
    • 7.5. Lung Cancer
      • 7.5.1. Global cancer profiling market for lung cancer, 2016-2025 (USD Billion)
    • 7.6. Melanoma Cancer
      • 7.6.1. Global cancer profiling market for melanoma cancer, 2016-2025 (USD Billion)
    • 7.7. Others
      • 7.7.1. Global cancer profiling market for others, 2016-2025 (USD Billion)
  • Chapter 8. Global Cancer Profiling Market - Application Analysis
    • 8.1. Global cancer profiling market: Application overview
      • 8.1.1. Global cancer profiling market revenue share, by application, 2018 and 2025
    • 8.2. Personalized Cancer Medicine
      • 8.2.1. Global cancer profiling market for personalized cancer medicine, 2016-2025 (USD Billion)
    • 8.3. Oncological Diagnostics
      • 8.3.1. Global cancer profiling market for oncological diagnostics, 2016-2025 (USD Billion)
    • 8.4. Research
      • 8.4.1. Global cancer profiling market for research, 2016-2025 (USD Billion)
    • 8.5. Others
      • 8.5.1. Global cancer profiling market for others, 2016-2025 (USD Billion)
  • Chapter 9. Global Cancer Profiling Market - Regional Analysis
    • 9.1. Global cancer profiling market: Regional overview
      • 9.1.1. Global cancer profiling market revenue share, by region, 2018 and 2025
    • 9.2. North America
      • 9.2.1. North America cancer profiling market, 2016-2025 (USD Billion)
      • 9.2.2. North America cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
      • 9.2.3. North America cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
      • 9.2.4. North America cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
      • 9.2.5. North America cancer profiling market revenue, by application, 2016-2025 (USD Billion)
      • 9.2.6. The U.S.
        • 9.2.6.1. The U.S. cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
        • 9.2.6.2. The U.S. cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
        • 9.2.6.3. The U.S. cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
        • 9.2.6.4. The U.S. cancer profiling market revenue, by application, 2016-2025 (USD Billion)
      • 9.2.7. Canada
        • 9.2.7.1. Canada cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
        • 9.2.7.2. Canada cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
        • 9.2.7.3. Canada cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
        • 9.2.7.4. Canada cancer profiling market revenue, by application, 2016-2025 (USD Billion)
    • 9.3. Europe
      • 9.3.1. Europe cancer profiling market, 2016-2025 (USD Billion)
      • 9.3.2. Europe cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
      • 9.3.3. Europe cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
      • 9.3.4. Europe cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
      • 9.3.5. Europe cancer profiling market revenue, by application, 2016-2025 (USD Billion)
      • 9.3.6. UK
        • 9.3.6.1. UK cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
        • 9.3.6.2. UK cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
        • 9.3.6.3. UK cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
        • 9.3.6.4. UK cancer profiling market revenue, by application, 2016-2025 (USD Billion)
      • 9.3.7. Germany
        • 9.3.7.1. Germany cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
        • 9.3.7.2. Germany cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
        • 9.3.7.3. Germany cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
        • 9.3.7.4. Germany cancer profiling market revenue, by application, 2016-2025 (USD Billion)
      • 9.3.8. France
        • 9.3.8.1. France cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
        • 9.3.8.2. France cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
        • 9.3.8.3. France cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
        • 9.3.8.4. France cancer profiling market revenue, by application, 2016-2025 (USD Billion)
      • 9.3.9. Rest of Europe
        • 9.3.9.1. Rest of Europe cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
        • 9.3.9.2. Rest of Europe cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
        • 9.3.9.3. Rest of Europe cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
        • 9.3.9.4. Rest of Europe cancer profiling market revenue, by application, 2016-2025 (USD Billion)
    • 9.4. Asia Pacific
      • 9.4.1. Asia Pacific cancer profiling market, 2016-2025 (USD Billion)
      • 9.4.2. Asia Pacific cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
      • 9.4.3. Asia Pacific cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
      • 9.4.4. Asia Pacific cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
      • 9.4.5. Asia Pacific cancer profiling market revenue, by application, 2016-2025 (USD Billion)
      • 9.4.6. China
        • 9.4.6.1. China cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
        • 9.4.6.2. China cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
        • 9.4.6.3. China cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
        • 9.4.6.4. China cancer profiling market revenue, by application, 2016-2025 (USD Billion)
      • 9.4.7. Japan
        • 9.4.7.1. Japan cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
        • 9.4.7.2. Japan cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
        • 9.4.7.3. Japan cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
        • 9.4.7.4. Japan cancer profiling market revenue, by application, 2016-2025 (USD Billion)
      • 9.4.8. India
        • 9.4.8.1. India cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
        • 9.4.8.2. India cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
        • 9.4.8.3. India cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
        • 9.4.8.4. India cancer profiling market revenue, by application, 2016-2025 (USD Billion)
      • 9.4.9. Rest of Asia Pacific
        • 9.4.9.1. Rest of Asia Pacific cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
        • 9.4.9.2. Rest of Asia Pacific cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
        • 9.4.9.3. Rest of Asia Pacific cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
        • 9.4.9.4. Rest of Asia Pacific cancer profiling market revenue, by application, 2016-2025 (USD Billion)
    • 9.5. Latin America
      • 9.5.1. Latin America cancer profiling market, 2016-2025 (USD Billion)
      • 9.5.2. Latin America cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
      • 9.5.3. Latin America cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
      • 9.5.4. Latin America cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
      • 9.5.5. Latin America cancer profiling market revenue, by application, 2016-2025 (USD Billion)
      • 9.5.6. Brazil
        • 9.5.6.1. Brazil cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
        • 9.5.6.2. Brazil cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
        • 9.5.6.3. Brazil cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
        • 9.5.6.4. Brazil cancer profiling market revenue, by application, 2016-2025 (USD Billion)
      • 9.5.7. Rest of Latin America
        • 9.5.7.1. Rest of Latin America cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
        • 9.5.7.2. Rest of Latin America cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
        • 9.5.7.3. Rest of Latin America cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
        • 9.5.7.4. Rest of Latin America cancer profiling market revenue, by application, 2016-2025 (USD Billion)
    • 9.6. The Middle East and Africa
      • 9.6.1. The Middle East and Africa cancer profiling market, 2016-2025 (USD Billion)
      • 9.6.2. The Middle East and Africa cancer profiling market revenue, by technique, 2016-2025 (USD Billion)
      • 9.6.3. The Middle East and Africa cancer profiling market revenue, by technology, 2016-2025 (USD Billion)
      • 9.6.4. The Middle East and Africa cancer profiling market revenue, by cancer type, 2016-2025 (USD Billion)
      • 9.6.5. The Middle East and Africa cancer profiling market revenue, by application, 2016-2025 (USD Billion)
  • Chapter 10. Company Profile
    • 10.1. Illumina
      • 10.1.1. Overview
      • 10.1.2. Financials
      • 10.1.3. Product Portfolio
      • 10.1.4. Business Strategy
      • 10.1.5. Recent Developments
    • 10.2. QIAGEN
      • 10.2.1. Overview
      • 10.2.2. Financials
      • 10.2.3. Product Portfolio
      • 10.2.4. Business Strategy
      • 10.2.5. Recent Developments
    • 10.3. NeoGenomics Laboratories
      • 10.3.1. Overview
      • 10.3.2. Financials
      • 10.3.3. Product Portfolio
      • 10.3.4. Business Strategy
      • 10.3.5. Recent Developments
    • 10.4. HTG Molecular Diagnostics
      • 10.4.1. Overview
      • 10.4.2. Financials
      • 10.4.3. Product Portfolio
      • 10.4.4. Business Strategy
      • 10.4.5. Recent Developments
    • 10.5. Genomic Health
      • 10.5.1. Overview
      • 10.5.2. Financials
      • 10.5.3. Product Portfolio
      • 10.5.4. Business Strategy
      • 10.5.5. Recent Developments
    • 10.6. Caris Life Sciences
      • 10.6.1. Overview
      • 10.6.2. Financials
      • 10.6.3. Product Portfolio
      • 10.6.4. Business Strategy
      • 10.6.5. Recent Developments
    • 10.7. Helomics Corporation
      • 10.7.1. Overview
      • 10.7.2. Financials
      • 10.7.3. Product Portfolio
      • 10.7.4. Business Strategy
      • 10.7.5. Recent Developments
    • 10.8. NanoString Technologies
      • 10.8.1. Overview
      • 10.8.2. Financials
      • 10.8.3. Product Portfolio
      • 10.8.4. Business Strategy
      • 10.8.5. Recent Developments
    • 10.9. Oxford Gene Technologies
      • 10.9.1. Overview
      • 10.9.2. Financials
      • 10.9.3. Product Portfolio
      • 10.9.4. Business Strategy
      • 10.9.5. Recent Developments
    • 10.10. RiboMed Biotechnologies
      • 10.10.1. Overview
      • 10.10.2. Financials
      • 10.10.3. Product Portfolio
      • 10.10.4. Business Strategy
      • 10.10.5. Recent Developments